William Pickering
Stock Analyst at Bernstein
(1.47)
# 3,536
Out of 5,090 analysts
30
Total ratings
52.94%
Success rate
-1.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $9.55 | -5.76% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $181.30 | -13.40% | 1 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $95 → $88 | $53.40 | +64.79% | 5 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $9.61 | +50.88% | 2 | Oct 28, 2025 | |
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $71.63 | +0.52% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $718.36 | +8.72% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $22.26 | -41.60% | 1 | Jul 29, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $458.12 | -32.33% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $61.44 | -60.94% | 2 | Nov 29, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $81.68 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $455.48 | - | 5 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $37 | $27.09 | +36.58% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.43 | +319.58% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $56.88 | -22.64% | 1 | Mar 21, 2023 |
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $9.55
Upside: -5.76%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $181.30
Upside: -13.40%
BioMarin Pharmaceutical
Nov 3, 2025
Maintains: Outperform
Price Target: $95 → $88
Current: $53.40
Upside: +64.79%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $9.61
Upside: +50.88%
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $71.63
Upside: +0.52%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $718.36
Upside: +8.72%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $22.26
Upside: -41.60%
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $458.12
Upside: -32.33%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $61.44
Upside: -60.94%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $81.68
Upside: -
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $455.48
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $27.09
Upside: +36.58%
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.43
Upside: +319.58%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $56.88
Upside: -22.64%